Ryan J. Watts

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Tyler Nielsen, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ryan J. Watts:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Denali Therapeutics Inc. President and CEO, Director Common Stock 2.15M $31.9M $14.81 03 Sep 2025 Indirect
Denali Therapeutics Inc. President and CEO, Director Common Stock 253K $3.75M $14.81 03 Sep 2025 Direct
Denali Therapeutics Inc. President and CEO, Director Stock Option (right to buy) 20.4K 09 Jul 2025 Direct

Insider Reports Filed by Ryan J. Watts

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DNLI Denali Therapeutics Inc. 03 Sep 2025 1 $0 4 President and CEO, Director 05 Sep 2025, 16:43
DNLI Denali Therapeutics Inc. 09 Jul 2025 5 -$6.91M 4 President and CEO, Director 11 Jul 2025, 17:13
DNLI Denali Therapeutics Inc. 06 Jan 2025 2 -$751K 4 President and CEO, Director 08 Jan 2025, 20:24
DNLI Denali Therapeutics Inc. 03 Jan 2025 2 $0 4 President and CEO, Director 07 Jan 2025, 18:59
DNLI Denali Therapeutics Inc. 18 Oct 2024 3 -$1.08M 4 President and CEO, Director 22 Oct 2024, 16:30
DNLI Denali Therapeutics Inc. 20 Aug 2024 1 -$53.8K 4 President and CEO, Director 22 Aug 2024, 16:16
DNLI Denali Therapeutics Inc. 29 Mar 2024 1 $0 4 President and CEO, Director 29 Mar 2024, 17:59
DNLI Denali Therapeutics Inc. 13 Feb 2024 1 -$166K 4 President and CEO, Director 15 Feb 2024, 21:15
DNLI Denali Therapeutics Inc. 09 Jan 2024 1 -$155K 4 President and CEO, Director 11 Jan 2024, 17:28
DNLI Denali Therapeutics Inc. 05 Jan 2024 1 -$340K 4 President and CEO, Director 09 Jan 2024, 19:33
DNLI Denali Therapeutics Inc. 03 Jan 2024 2 $0 4 President and CEO, Director 05 Jan 2024, 17:56
DNLI Denali Therapeutics Inc. 21 Aug 2023 1 -$52.2K 4 President and CEO, Director 23 Aug 2023, 16:32
DNLI Denali Therapeutics Inc. 10 Aug 2023 3 -$61.5K 4 President and CEO, Director 14 Aug 2023, 17:13
DNLI Denali Therapeutics Inc. 16 Jun 2023 3 -$1.54M 4 President and CEO, Director 20 Jun 2023, 18:28
DNLI Denali Therapeutics Inc. 20 Apr 2023 6 -$612K 4 President and CEO, Director 24 Apr 2023, 19:10
DNLI Denali Therapeutics Inc. 13 Feb 2023 4 -$1M 4 President and CEO, Director 15 Feb 2023, 18:01
DNLI Denali Therapeutics Inc. 09 Feb 2023 4 -$816K 4 President and CEO, Director 13 Feb 2023, 18:14
DNLI Denali Therapeutics Inc. 05 Jan 2023 1 -$137K 4 President and CEO, Director 09 Jan 2023, 20:41
DNLI Denali Therapeutics Inc. 03 Jan 2023 3 -$144K 4 President and CEO, Director 05 Jan 2023, 20:07
DNLI Denali Therapeutics Inc. 19 Aug 2022 1 -$79.9K 4 President and CEO, Director 23 Aug 2022, 16:48
DNLI Denali Therapeutics Inc. 11 Feb 2022 1 -$330K 4 President and CEO, Director 15 Feb 2022, 17:58
DNLI Denali Therapeutics Inc. 09 Feb 2022 5 $298K 4 President and CEO, Director 11 Feb 2022, 16:19
DNLI Denali Therapeutics Inc. 05 Jan 2022 1 -$224K 4 President and CEO, Director 07 Jan 2022, 17:06
DNLI Denali Therapeutics Inc. 03 Jan 2022 2 $0 4 President and CEO, Director 05 Jan 2022, 18:03
DNLI Denali Therapeutics Inc. 01 Dec 2021 3 -$824K 4 President and CEO, Director 03 Dec 2021, 15:23
DNLI Denali Therapeutics Inc. 01 Nov 2021 2 -$912K 4 President and CEO, Director 03 Nov 2021, 17:32
DNLI Denali Therapeutics Inc. 01 Oct 2021 3 -$924K 4 President and CEO, Director 05 Oct 2021, 16:27
DNLI Denali Therapeutics Inc. 01 Sep 2021 2 -$1M 4 President and CEO, Director 03 Sep 2021, 06:53
DNLI Denali Therapeutics Inc. 19 Aug 2021 2 -$118K 4 President and CEO, Director 23 Aug 2021, 20:25
DNLI Denali Therapeutics Inc. 02 Aug 2021 2 -$942K 4 President and CEO, Director 04 Aug 2021, 19:14
DNLI Denali Therapeutics Inc. 01 Jul 2021 3 -$1.42M 4 President and CEO, Director 06 Jul 2021, 16:14
DNLI Denali Therapeutics Inc. 01 Jun 2021 4 -$1.13M 4 President and CEO, Director 03 Jun 2021, 20:08